Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sezary syndrome
Gao, C; McCormack, C; van der Weyden, C; Goh, MS; Campbell, BA; Twigger, R; Buelens, O; Harrison, SJ; Khoo, C; Lade, S; Prince, HM
(2019), Blood, 1346-1350
Maintaining a fit T-cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T-cell therapies
Dickinson, M; Weinkove, R
(2019), Intern. Med. J., 1338-1338
DOI: 10.1111/imj.14453
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
Rashidi, A; Hamadani, M; Zhang, MJ; Wang, HL; Abdel-Azim, H; Aljurf, M; Assal, A; Bajel, A; Bashey, A; Battiwalla, M; Beitinjaneh, AM; Bejanyan, N; Bhatt, VR; Bolanos-Meade, J; Byrne, M; Cahn, JY; Cairo, M; Ciurea, S; Copelan, E; Cutler, C; Daly, A; Diaz, MA; Farhadfar, N; Gale, RP; Ganguly, S; Grunwald, MR; Hahn, T; Hashmi, S; Hildebrandt, GC; Holland, HK; Hossain, N; Kanakry, CG; Kharfan-Dabaja, MA; Khera, N; Koc, Y; Lazarus, HM; Lee, JW; Maertens, J; Martino, R; McGuirk, J; Munker, R; Murthy, HS; Nakamura, R; Nathan, S; Nishihori, T; Palmisiano, N; Patel, S; Pidala, J; Olin, R; Olsson, RF; Oran, B; Ringden, O; Rizzieri, D; Rowe, J; Savoie, ML; Schultz, KR; Seo, S; Shaffer, BC; Singh, A; Solh, M; Stockerl-Goldstein, K; Verdonck, LF; Wagner, J; Waller, EK; De Lima, M; Sandmaier, BM; Litzow, M; Weisdorf, D; Romee, R; Saber, W
(2019), Blood Adv., 1826-1836
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
Birkinshaw, RW; Gong, JN; Luo, CS; Lio, D; White, CA; Anderson, MA; Blombery, P; Lessene, G; Majewski, IJ; Thijssen, R; Roberts, AW; Huang, DCS; Colman, PM; Czabotar, PE
(2019), Nat. Commun.
A Retrospective Evaluation of Risk of Peripartum Cardiac Dysfunction in Survivors of Childhood, Adolescent and Young Adult Malignancies
Chait-Rubinek, L; Mariani, JA; Goroncy, N; Herschtal, A; Wheeler, GC; Dwyer, MK; Seymour, JF; Campbell, BA
(2019), Cancers
Pediatric aplastic anemia treatment patterns and responses; power in the numbers
Fox, LC; Ritchie, DS
(2019), Haematologica, 1909-1912
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression
Seymour, JF; Marcus, R; Davies, A; Gallop-Evans, E; Grigg, A; Haynes, A; Herold, M; Illmer, T; Nilsson-Ehle, H; Sokler, M; Dunzinger, U; Nielsen, T; Launonen, A; Hiddemann, W
(2019), Haematologica, 1202-1208
Further Examining the TROG 99.03 Trial in Early-Stage Follicular Lymphoma: Cure Rate and the Role of Positron Emission Tomography Reply
MacManus, M; Fisher, R; McClure, B; Seymour, JF
(2019), J. Clin. Oncol., 257-+
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
Bachy, E; Seymour, JF; Feugier, P; Offner, F; Lopez-Guillermo, A; Belada, D; Xerri, L; Catalano, JV; Brice, P; Lemonnier, F; Martin, A; Casasnovas, O; Pedersen, LM; Dorvaux, V; Simpson, D; Leppa, S; Gabarre, J; da Silva, MG; Glaisner, S; Ysebaert, L; Vekhoff, A; Intragumtornchai, T; Le Gouill, S; Lister, A; Estell, JA; Milone, G; Sonet, A; Farhi, J; Zeuner, H; Tilly, H; Salles, G
(2019), J. Clin. Oncol., 2815-+
DOI: 10.1200/JCO.19.01073
Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study
Kater, AP; Seymour, JF; Hillmen, P; Eichhorst, B; Langerak, AW; Owen, C; Verdugo, M; Wu, J; Punnoose, EA; Jiang, YW; Wang, J; Boyer, M; Humphrey, K; Mobasher, M; Kipps, TJ
(2019), J. Clin. Oncol., 269-+
DOI: 10.1200/JCO.18.01580
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia
Mehta, RS; Holtan, SG; Wang, T; Hemmer, MT; Spellman, SR; Arora, M; Couriel, DR; Alousi, AM; Pidala, J; Abdel-Azim, H; Ahmed, I; Aljurf, M; Askar, M; Auletta, JJ; Bhatt, V; Bredeson, C; Chhabra, S; Gadalla, S; Gajewski, J; Gale, RP; Gergis, U; Hematti, P; Hildebrandt, GC; Inamoto, Y; Kitko, C; Khandelwal, P; MacMillan, ML; Majhail, N; Marks, DI; Mehta, P; Nishihori, T; Olsson, RF; Pawarode, A; Diaz, MA; Prestidge, T; Qayed, M; Rangarajan, H; Ringden, O; Saad, A; Savani, BN; Seo, S; Shah, A; Shah, N; Schultz, KR; Solh, M; Spitzer, T; Szer, J; Teshima, T; Verdonck, LF; Williams, KM; Wirk, B; Wagner, J; Yared, JA; Weisdorf, DJ
(2019), Blood Adv., 1441-1449
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia
Minson, AG; Cummins, K; Fox, L; Costello, B; Yeung, D; Cleary, R; Forsyth, C; Tatarczuch, M; Burbury, K; Motorna, O; Shortt, J; Fleming, S; McQuillan, A; Schwarer, A; Harrup, R; Holmes, A; Ratnasingam, S; Chan, KL; Hsu, WH; Ashraf, A; Putt, F; Grigg, A
(2019), Blood Adv., 1084-1091
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial
Zelenetz, AD; Salles, G; Mason, KD; Casulo, C; Le Gouill, S; Sehn, LH; Tilly, H; Cartron, G; Chamuleau, MED; Goy, A; Tam, CS; Lugtenburg, PJ; Petrich, AM; Sinha, A; Samineni, D; Herter, S; Ingalla, E; Szafer-Glusman, E; Klein, C; Sampath, D; Kornacker, M; Mobasher, M; Morschhauser, F
(2019), Blood, 1964-1976
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Tam, CS; Trotman, J; Opat, S; Burger, JA; Cull, G; Gottlieb, D; Harrup, R; Johnston, PB; Marlton, P; Munoz, J; Seymour, JF; Simpson, D; Tedeschi, A; Elstrom, R; Yu, YL; Tang, ZY; Han, L; Huang, J; Novotny, W; Wang, L; Roberts, AW
(2019), Blood, 851-859
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
Roberts, AW; Ma, S; Kipps, TJ; Coutre, SE; Davids, MS; Eichhorst, B; Hallek, M; Byrd, JC; Humphrey, K; Zhou, L; Chyla, B; Nielsen, J; Potluri, J; Kim, SY; Verdugo, M; Stilgenbauer, S; Wierda, WG; Seymour, JF
(2019), Blood, 111-122
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
Blombery, P; Anderson, MA; Gong, JN; Thijssen, R; Birkinshaw, RW; Thompson, ER; Teh, CE; Nguyen, T; Xu, Z; Flensburg, C; Lew, TE; Majewski, IJ; Gray, DHD; Westerman, DA; Tam, CS; Seymour, JF; Czabotar, PE; Huang, DCS; Roberts, AW
(2019), Cancer Discov., 342-353
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
Brighton, TA; Khot, A; Harrison, SJ; Ghez, D; Weiss, BM; Kirsch, A; Magen, H; Gironella, M; Oriol, A; Streetly, M; Kranenburg, B; Qin, X; Bandekar, R; Hu, P; Guilfoyle, M; Qi, M; Nemat, S; Goldschmidt, H
(2019), Clin. Cancer Res., 3772-3775
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
Mehta, A; Kuter, DJ; Salek, SS; Belmatoug, N; Bembi, B; Bright, J; vom Dahl, S; Deodato, F; Di Rocco, M; Goker-Alpan, O; Hughes, DA; Lukina, EA; Machaczka, M; Mengel, E; Nagral, A; Nakamura, K; Narita, A; Oliveri, B; Pastores, G; Perez-Lopez, J; Ramaswami, U; Schwartz, IV; Szer, J; Weinreb, NJ; Zimran, A
(2019), Intern. Med. J., 578-591
DOI: 10.1111/imj.14156
Role of bone marrow biopsy for fever of unknown origin in the contemporary Australian context
Hong, FS; Fox, LC; Chai, KL; Htun, K; Clucas, D; Morgan, S; Cole-Sinclair, MF; Juneja, S
(2019), Intern. Med. J., 850-854
DOI: 10.1111/imj.14147
Revisiting acquired aplastic anaemia: current concepts in diagnosis and management
Clucas, DB; Fox, LC; Wood, EM; Hong, FS; Gibson, J; Bajel, A; Szer, J; Blombery, P; McQuilten, ZK; Hiwase, D; Firkin, F; Cole-Sinclair, MF; Firkin, F; Badoux, X; Bajel, A; Blombery, P; Cole, C; Cole-Sinclair, M; Fox, L; Forsyth, C; Gibson, J; Hiwase, D; Hong, F; Johnston, A; McQuilten, Z; Mills, T; Opat, S; Roncolato, F; Szer, J; Wood, E
(2019), Intern. Med. J., 152-159
DOI: 10.1111/imj.14140
Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma
Blombery, P; Birkinshaw, RW; Nguyen, T; Gong, JN; Thompson, ER; Xu, Z; Westerman, DA; Czabotar, PE; Dickinson, M; Huang, DCS; Seymour, JF; Roberts, AW
(2019), Br. J. Haematol., E188-E191
DOI: 10.1111/bjh.16069
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance
Wight, JC; Yue, M; Keane, C; Johnston, A; Linton, K; Chin, C; Wai, SH; Talaulikar, D; Gasiorowski, R; Cheah, CY; Gregory, GP; Dickinson, M; Minson, A; Coombes, C; Ku, M; Lam, S; Hawkes, EA
(2019), Br. J. Haematol., 174-184
DOI: 10.1111/bjh.16064
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy
Jamois, C; Gibiansky, E; Gibiansky, L; Buchheit, V; Sahin, D; Cartron, G; Marcus, R; Hiddemann, W; Seymour, JF; Strefford, JC; Hargreaves, CE; Meneses-Lorente, G; Frey, N; Fingerle-Rowson, G
(2019), Br. J. Clin. Pharmacol., 1495-1506
DOI: 10.1111/bcp.13920
Management of patients with follicular lymphoma treated first line with obinutuzumab
Opat, S; Dickinson, M; Cheah, CY; Tam, C; Boulos, J; Thorburn, AN; Trotman, J
(2019), Asia-Pac. J. Clin. Oncol., 3-11
DOI: 10.1111/ajco.13153
Mechanisms, mishaps and manipulation of iron uptake
Bennett, C; Pasricha, SR
(2019), Hemasphere, 104-108
Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study
Papanicolaou, GA; Ustun, C; Young, JAH; Chen, M; Kim, S; Ahn, KW; Komanduri, K; Lindemans, C; Auletta, JJ; Riches, ML; Abdel-Azim, H; Ahmed, IA; Aljurf, M; Antin, J; Ballen, KK; Beitinjaneh, A; Brown, VI; Cerny, J; Champlin, R; Chao, N; Chhabra, S; Dahi, PB; Daly, A; Dandoy, C; Dvorak, CC; Forman, S; Freytes, C; Ganguly, S; Hashmi, SK; Kharfan-Dabaja, MA; Lazarus, H; Ljungman, P; Malone, AK; Murthy, G; Nishihori, T; Page, K; Pingali, R; Reddy, V; Saad, A; Savani, BN; Seftel, M; Szer, J; Vij, R; Weisdorf, D; William, BM; Williams, K; Wirk, B; Yared, J; Yu, LC
(2019), Clin. Infect. Dis., 1771-1779
DOI: 10.1093/cid/ciz031
High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing
Meher-Homji, Z; Tam, CS; Siderov, J; Seymour, JF; Holmes, NE; Chua, KYL; Phillips, EJ; Slavin, MA; Trubiano, JA
(2019), Leuk. Lymphoma, 3455-3460
Where do we currently stand with T-cell prolymphocytic leukemia?
Khot, A
(2019), Leuk. Lymphoma, 563-565
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
Agarwal, R; Chan, YC; Tam, CS; Hunter, T; Vassiliadis, D; Teh, CE; Thijssen, R; Yeh, P; Wong, SQ; Ftouni, S; Lam, EYN; Anderson, MA; Pott, C; Gilan, O; Bell, CC; Knezevic, K; Blombery, P; Rayeroux, K; Zordan, A; Li, J; Huang, DCS; Wall, M; Seymour, JF; Gray, DHD; Roberts, AW; Dawson, MA; Dawson, SJ
(2019), Nat. Med., 119-+